Profound Medical Corp
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping… Read more
Market Cap & Net Worth: Profound Medical Corp (PROF)
Profound Medical Corp (NASDAQ:PROF) has a market capitalization of $212.31 Million ($212.31 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15872 globally and #6179 in its home market, demonstrating a 11.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Profound Medical Corp's stock price $5.85 by its total outstanding shares 36292972 (36.29 Million).
Profound Medical Corp Market Cap History: 2016 to 2026
Profound Medical Corp's market capitalization history from 2016 to 2026. Data shows change from $288.78 Million to $212.31 Million (-5.51% CAGR).
Index Memberships
Profound Medical Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #426 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1501 of 3165 |
Weight: Profound Medical Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Profound Medical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Profound Medical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
26.81x
Profound Medical Corp's market cap is 26.81 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $236.85 Million | $3.90 Million | -$14.97 Million | 60.73x | N/A |
| 2018 | $152.43 Million | $1.91 Million | -$15.24 Million | 79.78x | N/A |
| 2019 | $397.41 Million | $4.17 Million | -$15.22 Million | 95.21x | N/A |
| 2020 | $746.18 Million | $7.30 Million | -$21.62 Million | 102.16x | N/A |
| 2021 | $407.57 Million | $6.87 Million | -$30.70 Million | 59.30x | N/A |
| 2022 | $395.23 Million | $6.68 Million | -$28.67 Million | 59.16x | N/A |
| 2023 | $308.13 Million | $7.20 Million | -$28.57 Million | 42.80x | N/A |
| 2024 | $272.56 Million | $10.17 Million | -$26.48 Million | 26.81x | N/A |
Competitor Companies of PROF by Market Capitalization
Companies near Profound Medical Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Profound Medical Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Profound Medical Corp Historical Marketcap From 2016 to 2026
Between 2016 and today, Profound Medical Corp's market cap moved from $288.78 Million to $ 212.31 Million, with a yearly change of -5.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $212.31 Million | -25.67% |
| 2025 | $285.63 Million | +4.79% |
| 2024 | $272.56 Million | -11.54% |
| 2023 | $308.13 Million | -22.04% |
| 2022 | $395.23 Million | -3.03% |
| 2021 | $407.57 Million | -45.38% |
| 2020 | $746.18 Million | +87.76% |
| 2019 | $397.41 Million | +160.71% |
| 2018 | $152.43 Million | -35.64% |
| 2017 | $236.85 Million | -17.98% |
| 2016 | $288.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Profound Medical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $212.31 Million USD |
| MoneyControl | $212.31 Million USD |
| MarketWatch | $212.31 Million USD |
| marketcap.company | $212.31 Million USD |
| Reuters | $212.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.